Seattle Genetics pulls out of $2 billion bid for cancer drug

Bothell-based Seattle Genetics, the region’s biggest biotech firm, spiked a $2 billion deal to manfuacture and distribute an experimental tumor fighting drug.

The company announced in February that it had reached a deal with New Jersey-based Immunomedics for exclusive worldwide rights to develop IMMU-132, which could fight tumors in breast, lung and bladder cancers. Seattle Genetics agreed to pay $250 million upfront, with licensing payments potentially reaching as much as $2 billion.

A large shareholder in Immunomedics, venBio Select Advisor thought the deal undervalued the anti-cancer drug. In March, it filed a lawsuit to block the agreement.

Last week, shareholders led by venBio ousted the husband-and-wife team leading Immunomedics and approved a plan for the company to make and distribute IMMU-132.

The deal would be “nice to have,” but is “not a must have,” Seattle Genetics’ chief operating officer Eric Dobmeier said, according to Seeking Alpha, an investment news website.

Seattle Genetics has grown substantially in recent years, and expects to grow further in the next few years.

The company will focus its “full attention and resources to our promising pipeline and the substantial opportunities in front of us,” chief executive officer Clay Siegall said.

Its current product, Adcetris, could soon become a go-to drug for treating one of the main types of lymphoma. Seattle Genetics expects to bring several drugs to market in the next few years. The company plans to add 200 employees this year, raising its workforce to more than 1,100.

Dan Catchpole: 425-339-3454; dcatchpole@heraldnet.com; Twitter: @dcatchpole.




In consideration of how we voice our opinions in the modern world, we’ve closed comments on our websites. We value the opinions of our readers and we encourage you to keep the conversation going.

Please feel free to share your story tips by emailing editor@bothell-reporter.com.

To share your opinion for publication, submit a letter through our website https://www.bothell-reporter.com/submit-letter/. Include your name, address and daytime phone number. (We’ll only publish your name and hometown.) We reserve the right to edit letters, but if you keep yours to 300 words or less, we won’t ask you to shorten it.

More in Business

A new measure from the King County Council could increase flexibility for businesses in rural areas of King County. File photo
County measure would increase flexibility for businesses in rural areas

Staff report Legislation the King County Council passed June 23 could lead… Continue reading

Like similar businesses across King, Snohomish and Pierce counties, Bothell restaurant Hana Sushi closed due to public-health concerns. Sound Publishing file photo
Inslee changes course, says diners won’t have to sign in

Restaurants may still ask customers for information that contact tracers could use to stop an outbreak.

Businesses, nonprofits asked to participate in COVID-19 impact survey

Regional effort in King, Snohomish and Pierce counties

Construction worker installs siding to a building in Snoqualmie. File photo
Inslee gives construction a green light

It was unclear when sites would re-open, but employees will have to have PPE and stay six feet apart.

Report shows severity of COVID-19 impacts on hotels nationwide

70% of employees laid off or furloughed, eight in 10 hotel rooms empty

State processes record number of applications for unemployment benefits

Employment Security Department had challenges with the volume

Cantwell calls for nationwide support for local media hurt by COVID-19 pandemic

Remarks come on Senate floor: ‘We need the media. …and need to help them’

Gyms, fitness centers must allow members to cancel memberships or face legal consequences

State attorney general responds to consumer complaints during COVID-19 outbreak

Boeing to resume Washington airplane production next week

More than 27,000 employees are expected to return to work at the Everett campus starting Monday.